City

Clinical trials near Rochester, United States

Active studies with a listed research site in Rochester, United States.

34active studies

19recruiting now

16countries represented

56largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 2

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Obesity, OverweightCondition

LY3305677, LY3841136Treatment

Argentina, United States56 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT06143956See eligibility →

Recruiting nowPhase 4

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Psoriatic Arthritis, Overweight or ObesityCondition

TirzepatideTreatment

Puerto Rico, United States55 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT06864026See eligibility →

Recruiting nowPhase 3

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Obesity or OverweightCondition

Maridebart CafraglutideTreatment

Puerto Rico, United States45 locations

AmgenSponsor

Updated 2026-08-27 · NCT07575399See eligibility →

Recruiting nowPhase 2

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Overweight, ObesityCondition

Macupatide, EloralintideTreatment

United States40 locations

Eli Lilly and CompanySponsor

Updated 2026-08-06 · NCT07589608See eligibility →

Recruiting nowNot applicable

Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity

ObesityCondition

Meal StudyTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-08-05 · NCT07031297See eligibility →

Recruiting nowPhase 4

Fibrosis Lessens After Metabolic Surgery

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver DiseaseCondition

Metabolic surgery, Incretin-Based TherapyTreatment

Brazil, Canada22 locations

The Cleveland ClinicSponsor

Updated 2026-07-31 · NCT06374875See eligibility →

Recruiting nowNot applicable

Breastmilk in Response to a Bout of Exercise

Infant Development, Obesity, ChildhoodCondition

Pre-Pregnancy BMI, Pre-Pregnancy BMITreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-06-24 · NCT06892483See eligibility →

Recruiting nowNot applicable

Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial

ObesityCondition

Standard Lifestyle Intervention (SLI) program, Phenotype-tailored Lifestyle Intervention (PLI) programTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-06-11 · NCT06770049See eligibility →

Recruiting nowEarly Phase 1

Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation

ObesityCondition

Somatostatin, EpinephrineTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-05-22 · NCT06416969See eligibility →

Recruiting nowNot applicable

Circadian Rhythms in Human Adipose

Obesity, Abdominal, Feeding PatternsCondition

Continuous Feeding, Intermittent feedingTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-04-14 · NCT06891534See eligibility →

Recruiting nowEarly Phase 1

Regional Lipolysis Insulin Regulation

ObesityCondition

InsulinTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-04-13 · NCT06392854See eligibility →

Recruiting nowNot applicable

Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry

Breathing, Lung Function DecreasedCondition

OscillometerTreatment

United States1 locations

University of RochesterSponsor

Updated 2026-04-13 · NCT07356310See eligibility →

Recruiting nowPhase 4

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

Bipolar I Disorder, Bipolar II DisorderCondition

Group Therapy Program, semaglutideTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-03-11 · NCT07213466See eligibility →

Recruiting nowNot applicable

Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis

Obesity, MorbidCondition

Gastric sleeve/bariatric surgeryTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-03-03 · NCT03868592See eligibility →

Recruiting nowEarly Phase 1

Insulin Regulation of Lipolysis and Lipolysis Proteins

ObesityCondition

Immediate weight loss, PioglitazoneTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-01-28 · NCT03866408See eligibility →

Recruiting nowNot applicable

The Weight of Cardiovascular Disease

Cardiovascular Diseases, ObesityCondition

Intervention not listedTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2025-10-20 · NCT06053645See eligibility →

Recruiting nowNot applicable

Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study

Obesity & Overweight, Orthodontic TreatmentCondition

Intervention not listedTreatment

United States1 locations

University of RochesterSponsor

Updated 2025-10-20 · NCT07217756See eligibility →

Recruiting nowNot applicable

Weight Loss Through Mayo Clinic Diet

ObesityCondition

Mayo Clinic Diet, Usual CareTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2025-10-07 · NCT06862375See eligibility →

Recruiting nowNot applicable

Exercise Response in Humans With Obesity

ObeseCondition

Treadmill Test, Strength TestTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2025-08-29 · NCT05857150See eligibility →

Opening soonPhase 4

Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)

Pouch, Ileal, Pouches, IleoanalCondition

Tirzepatide, LoperamideTreatment

United States5 locations

University of North Carolina, Chapel HillSponsor

Updated 2026-08-10 · NCT07756359See eligibility →

Invitation onlyPhase 4

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Infections Joint Prosthetic, Overweight or ObesityCondition

Cephalexin, DoxycyclineTreatment

United States2 locations

Mayo ClinicSponsor

Updated 2026-07-06 · NCT04297592See eligibility →

Invitation onlyNot applicable

Evaluating Benefit of Peptide Based Diet in Obese HEN Patients

ObesityCondition

Peptamen Intense VHP, Nestlé Health Science, SwitzerlandTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-01-26 · NCT05080699See eligibility →

Active, not recruitingPhase 2

A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Obesity, OverweightCondition

RO7204239, RO7204239 Matching PlaceboTreatment

Poland, Spain35 locations

Hoffmann-La RocheSponsor

Updated 2026-08-11 · NCT06965413See eligibility →

Active, not recruitingNot applicable

A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis

Obesity, Ulcerative ColitisCondition

Apollo Endoscopic Suture System, Lifestyle InterventionTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-08-06 · NCT05739162See eligibility →

Active, not recruitingPhase 2

A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Obesity, OverweightCondition

LY3841136, TirzepatideTreatment

Argentina, United States52 locations

Eli Lilly and CompanySponsor

Updated 2026-07-17 · NCT06603571See eligibility →

Active, not recruitingPhase 4

A Study of a Novel Precision Medicine Approach For Obesity

ObesityCondition

Semaglutide, PlaceboTreatment

United States2 locations

Mayo ClinicSponsor

Updated 2026-07-16 · NCT06814938See eligibility →

Active, not recruitingPhase 1

A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity

Obese But Otherwise Healthy ParticipantsCondition

CRB-913, PlaceboTreatment

United States15 locations

Corbus Pharmaceuticals Inc.Sponsor

Updated 2026-05-29 · NCT07310901See eligibility →

Active, not recruitingNot applicable

A Study of Adipose Tissue in Adaptive Responses to Exercise

Healthy, ObesityCondition

Adipose Tissue Biopsy, ExerciseTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-05-06 · NCT06053125See eligibility →

Active, not recruitingPhase 2

Aleniglipron Phase 2 Body Composition Study

Obesity, Overweight, or Chronic Weight ManagementCondition

aleniglipron or placeboTreatment

United States11 locations

Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsSponsor

Updated 2026-03-03 · NCT07169942See eligibility →

Active, not recruitingPhase 4

Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion

Healthy, Type 2 DiabetesCondition

Dextrose, Clinisol 15%Treatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-02-13 · NCT05264727See eligibility →

Active, not recruitingNot applicable

Bariatric Surgery Versus Diet Alone in the Bile Acid Pathway and Weight Loss

ObesityCondition

Roux-En-Y Gastric Bypass, Low-calorie DietTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2026-02-11 · NCT03238794See eligibility →

Active, not recruitingPhase 4

Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions

ObesityCondition

Semaglutide, TirzepatideTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2025-12-26 · NCT06801015See eligibility →

Active, not recruitingNot applicable

A Study of Time Restricted Eating in Obese Adults

OverweightCondition

Early time-restricted eating, Late time-restricted eatingTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2025-09-26 · NCT05660291See eligibility →

Active, not recruitingNot applicable

Exercise-stimulated Muscle Glucose Uptake in Upper Body Obesity

Upper Body ObesityCondition

ExerciseTreatment

United States1 locations

Mayo ClinicSponsor

Updated 2025-08-17 · NCT04532814See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Rochester, United States

Current studies

Related cities